Your browser doesn't support javascript.
loading
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma.
Jiang, Yan-Yi; Lin, De-Chen; Mayakonda, Anand; Hazawa, Masaharu; Ding, Ling-Wen; Chien, Wen-Wen; Xu, Liang; Chen, Ye; Xiao, Jin-Fen; Senapedis, William; Baloglu, Erkan; Kanojia, Deepika; Shang, Li; Xu, Xin; Yang, Henry; Tyner, Jeffrey W; Wang, Ming-Rong; Koeffler, H Phillip.
Afiliação
  • Jiang YY; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Lin DC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Mayakonda A; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Hazawa M; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Ding LW; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Chien WW; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Xu L; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Chen Y; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Xiao JF; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Senapedis W; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Baloglu E; Department of Drug Discovery, Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.
  • Kanojia D; Department of Drug Discovery, Karyopharm Therapeutics Inc., Newton, Massachusetts, USA.
  • Shang L; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Xu X; State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Yang H; State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Tyner JW; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Wang MR; Department of Cell, Developmental & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Koeffler HP; State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Gut ; 66(8): 1358-1368, 2017 08.
Article em En | MEDLINE | ID: mdl-27196599
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilenodiaminas / Pirimidinas / Acrilamidas / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Expressão Gênica / Aminopiridinas / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Gut Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilenodiaminas / Pirimidinas / Acrilamidas / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Expressão Gênica / Aminopiridinas / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Revista: Gut Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Singapura